Skip to main content
ADPKD

Polycystic Kidney Disease in Black Americans: Protecting Your Liver During Treatment

Certain medications for PKD may increase the risk of liver damage.

Lauren Smith, MAAlexandra Schwarz, MD
Written by Lauren Smith, MA | Reviewed by Alexandra Schwarz, MD
Updated on September 23, 2024
Featuring Scherly Leon, MDReviewed by Alexandra Schwarz, MD | September 23, 2024

One class of medication to treat polycystic kidney disease (PKD) is called vasopressin 2 receptor (V2R) antagonists. V2R antagonists may be very helpful for people with PKD, but one risk is that they may have harmful side effects to the liver in some people. 

In this video, learn tips to help protect the liver during PKD treatment with a V2R antagonist.

References

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

why trust our exports reliability shield

Why trust our experts?

Lauren Smith, MA
Written by:
Lauren Smith, MA
Lauren Smith, MA, has worked in health journalism since 2017. Before joining GoodRx, she was the senior health editor and writer for HealthiNation.
Alexandra Schwarz, MD
Reviewed by:
Alexandra Schwarz, MD
Alexandra Schwarz, MD, is a board-eligible sleep medicine physician and a board-certified family medicine physician. She is a member of both the AASM and the ABFM.
Green trust check markOur editorial standards
Green trust check markMeet our experts

Was this page helpful?

Latest articles

Does Polycystic Kidney Disease Run in Families?
Video play button

What Is Polycystic Kidney Disease? Causes, Risk Factors, and Symptoms

2:13
ADPKD: doctor examines back of patient-1405986130

Risk Factors for Adult Polycystic Kidney Disease and Who’s Most at Risk

by Karla Robinson, MD • Oct 1, 2024